These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31424258)

  • 1. Long-term peritoneal dialysis treatment provokes activation of genes related to adaptive immunity.
    Parikova A; Hruba P; Krediet RT; Krejcik Z; Stranecky V; Striz I; Viklicky O
    Physiol Res; 2019 Oct; 68(5):775-783. PubMed ID: 31424258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal dialysis induces alterations in the transcriptome of peritoneal cells before detectible peritoneal functional changes.
    Parikova A; Hruba P; Krejcik Z; Stranecky V; Franekova J; Krediet RT; Viklicky O
    Am J Physiol Renal Physiol; 2020 Jan; 318(1):F229-F237. PubMed ID: 31760769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis.
    Yokoi H; Kasahara M; Mori K; Ogawa Y; Kuwabara T; Imamaki H; Kawanishi T; Koga K; Ishii A; Kato Y; Mori KP; Toda N; Ohno S; Muramatsu H; Muramatsu T; Sugawara A; Mukoyama M; Nakao K
    Kidney Int; 2012 Jan; 81(2):160-9. PubMed ID: 21881556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Permanent loss of ultrafiltration capacity of the peritoneum in long-term peritoneal dialysis: an epidemiological study.
    Slingeneyer A; Canaud B; Mion C
    Nephron; 1983; 33(2):133-8. PubMed ID: 6835460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous ambulatory peritoneal dialysis impairs T lymphocyte selection in the peritoneum.
    Fricke H; Hartmann J; Sitter T; Steldinger R; Rieber P; Schiffl H
    Kidney Int; 1996 May; 49(5):1386-95. PubMed ID: 8731104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors increasing severity of peritonitis in long-term peritoneal dialysis patients.
    Park MS
    Adv Ren Replace Ther; 1998 Jul; 5(3):185-93. PubMed ID: 9686629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression profiling and ontology analysis of noncoding RNAs in peritoneal fibrosis induced by peritoneal dialysis fluid.
    Liu Y; Guo R; Hao G; Xiao J; Bao Y; Zhou J; Chen Q; Wei X
    Gene; 2015 Jun; 564(2):210-9. PubMed ID: 25827714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure.
    López-Cabrera M; Aguilera A; Aroeira LS; Ramírez-Huesca M; Pérez-Lozano ML; Jiménez-Heffernan JA; Bajo MA; del Peso G; Sánchez-Tomero JA; Selgas R
    Perit Dial Int; 2006; 26(1):26-34. PubMed ID: 16538870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal inflammation and fibrosis in C-reactive protein transgenic mice undergoing peritoneal dialysis solution treatment.
    Poon PY; Lan HY; Kwan BC; Huang XR; Chow KM; Szeto CC; Li PK
    Nephrology (Carlton); 2017 Feb; 22(2):125-132. PubMed ID: 26857687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in peritoneal response after exposure to low-GDP bicarbonate/lactate-buffered dialysis solution compared to conventional dialysis solution in a uremic mouse model.
    Vila Cuenca M; Keuning ED; Talhout W; Paauw NJ; van Ittersum FJ; Ter Wee PM; Beelen RHJ; Vervloet MG; Ferrantelli E
    Int Urol Nephrol; 2018 Jun; 50(6):1151-1161. PubMed ID: 29728994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal changes in patients on long-term peritoneal dialysis.
    Krediet RT; Struijk DG
    Nat Rev Nephrol; 2013 Jul; 9(7):419-29. PubMed ID: 23670085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal Cell-free DNA: an innovative method for determining acute cell damage in peritoneal membrane and for monitoring the recovery process after peritonitis.
    Virzì GM; Milan Manani S; Brocca A; Cantaluppi V; de Cal M; Pastori S; Tantillo I; Zambon R; Crepaldi C; Ronco C
    J Nephrol; 2016 Feb; 29(1):111-8. PubMed ID: 26012380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cancer antigen 125 by peritoneal mesothelial cells is not influenced by duration of peritoneal dialysis.
    Sanusi AA; Zweers MM; Weening JJ; de Waart DR; Struijk DG; Krediet RT
    Perit Dial Int; 2001; 21(5):495-500. PubMed ID: 11757834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smad7 transgene attenuates peritoneal fibrosis in uremic rats treated with peritoneal dialysis.
    Guo H; Leung JC; Lam MF; Chan LY; Tsang AW; Lan HY; Lai KN
    J Am Soc Nephrol; 2007 Oct; 18(10):2689-703. PubMed ID: 17855642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters.
    Rodrigues AS; Martins M; Korevaar JC; Silva S; Oliveira JC; Cabrita A; Castro e Melo J; Krediet RT
    Am J Nephrol; 2007; 27(1):84-91. PubMed ID: 17284895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term peritoneal dialysis-impact of peritoneal membrane changes and newer solutions.
    Krediet RT
    Int J Artif Organs; 1998 Aug; 21(8):437-9. PubMed ID: 9803343
    [No Abstract]   [Full Text] [Related]  

  • 17. Effluent hydroxyproline in experimental peritoneal dialysis.
    Vlijm A; de Waart DR; Zweers MM; Krediet RT
    Perit Dial Int; 2007; 27(2):210-3. PubMed ID: 17299162
    [No Abstract]   [Full Text] [Related]  

  • 18. Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties.
    Plum J; Hermann S; Fusshöller A; Schoenicke G; Donner A; Röhrborn A; Grabensee B
    Kidney Int Suppl; 2001 Feb; 78():S42-7. PubMed ID: 11168981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of peritoneal effluents on mesothelial cells in culture: cell proliferation and extracellular matrix regulation.
    Perfumo F; Altieri P; Degl'Innocenti ML; Ghiggeri GM; Caridi G; Trivelli A; Gusmano R
    Nephrol Dial Transplant; 1996 Sep; 11(9):1803-9. PubMed ID: 8918626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional and Transcriptomic Characterization of Peritoneal Immune-Modulation by Addition of Alanyl-Glutamine to Dialysis Fluid.
    Herzog R; Kuster L; Becker J; Gluexam T; Pils D; Spittler A; Bhasin MK; Alper SL; Vychytil A; Aufricht C; Kratochwill K
    Sci Rep; 2017 Jul; 7(1):6229. PubMed ID: 28740213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.